> top > docs > PMC:3585731 > spans > 9192-10103 > annotations

PMC:3585731 / 9192-10103 JSONTXT

Annnotations TAB JSON ListView MergeView

testone

Id Subject Object Predicate Lexical cue
T2893 588-596 Positive_regulation denotes promoted
T2892 403-410 Positive_regulation denotes induced
T2891 366-375 Negative_regulation denotes inhibitor
T2890 270-277 Positive_regulation denotes induced
T2889 54-61 Positive_regulation denotes induced
T2885 600-604 Protein denotes bFGF
T2884 398-402 Protein denotes TNFα
T2883 352-365 Protein denotes bFGF receptor
T2882 227-231 Protein denotes bFGF
T2881 127-156 Protein denotes bFGF receptor tyrosine kinase
T2880 25-29 Protein denotes bFGF
R1989 T2883 T2891 themeOf bFGF receptor,inhibitor
R1990 T2885 T2893 causeOf bFGF,promoted

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T3906 905-910 NN denotes death
T3905 893-904 JJ denotes necroptotic
T3904 890-892 TO denotes to
T3903 879-889 VB denotes contribute
T3902 876-878 TO denotes to
T3901 869-875 VB denotes appear
T3900 861-868 NN denotes factors
T3899 854-860 NN denotes growth
T3898 843-853 JJ denotes particular
T3897 840-842 IN denotes by
T3896 831-839 VB denotes mediated
T3895 824-830 NN denotes events
T3894 814-823 NN denotes signaling
T3893 805-813 JJ denotes specific
T3892 803-804 -COMMA- denotes ,
T3891 796-803 RB denotes Instead
T3890 789-794 VB denotes occur
T3889 786-788 TO denotes to
T3888 780-785 NN denotes death
T3887 772-779 VB denotes allowed
T3886 764-771 NN denotes factors
T3885 757-763 NN denotes growth
T3884 753-756 DT denotes all
T3883 749-752 RB denotes not
T3882 743-748 IN denotes since
T3881 733-742 NN denotes signaling
T3880 726-732 NN denotes factor
T3879 719-725 NN denotes growth
T3878 716-718 IN denotes of
T3877 704-715 NN denotes consequence
T3876 697-703 JJ denotes simple
T3875 695-696 DT denotes a
T3874 691-694 RB denotes not
T3873 688-690 VB denotes is
T3872 686-687 -COMMA- denotes ,
T3871 679-686 RB denotes however
T3870 677-678 -COMMA- denotes ,
T3869 666-677 NN denotes necroptosis
T3868 663-665 IN denotes of
T3867 653-662 NN denotes induction
T3866 649-652 DT denotes The
T3865 637-647 NN denotes conditions
T3864 632-636 JJ denotes free
T3863 626-631 NN denotes serum
T3862 622-625 CC denotes and
T3861 616-621 NN denotes serum
T3860 611-615 CC denotes both
T3859 605-610 IN denotes under
T3858 600-604 NN denotes bFGF
T3857 597-599 IN denotes by
T3856 588-596 VB denotes promoted
T3855 585-587 VB denotes is
T3854 576-584 NN denotes zVAD.fmk
T3853 573-575 IN denotes by
T3852 561-572 NN denotes necroptosis
T3851 558-560 IN denotes of
T3850 548-557 NN denotes induction
T3849 544-547 DT denotes the
T3848 539-543 IN denotes that
T3847 531-538 VB denotes suggest
T3846 526-530 NN denotes data
T3845 520-525 DT denotes these
T3844 518-519 -COMMA- denotes ,
T3843 511-518 RB denotes Overall
T3842 508-509 -RRB- denotes )
T3841 506-508 NN denotes 1A
T3840 501-505 NN denotes Fig.
T3839 500-501 -LRB- denotes (
T3838 492-499 NN denotes pathway
T3837 487-491 DT denotes this
T3836 483-486 IN denotes for
T3835 471-482 JJ denotes dispensable
T3834 465-470 VB denotes being
T3833 457-464 NN denotes factors
T3832 450-456 NN denotes growth
T3831 445-449 IN denotes with
T3830 434-444 JJ denotes consistent
T3829 432-433 -COMMA- denotes ,
T3828 431-432 -RRB- denotes )
T3827 429-431 NN denotes 1D
T3826 424-428 NN denotes Fig.
T3825 423-424 -LRB- denotes (
T3824 411-422 NN denotes necroptosis
T3823 398-410 JJ denotes TNFα-induced
T3822 388-397 VB denotes attenuate
T3821 385-387 TO denotes to
T3820 380-384 JJ denotes able
T3819 376-379 VB denotes was
T3818 366-375 NN denotes inhibitor
T3817 357-365 NN denotes receptor
T3816 352-356 NN denotes bFGF
T3815 344-351 CC denotes neither
T3814 342-343 -COMMA- denotes ,
T3813 334-342 NN denotes contrast
T3812 331-333 IN denotes In
T3811 328-329 -RRB- denotes )
T3810 326-328 NN denotes 1D
T3809 321-325 NNP denotes Fig.
T3808 320-321 -LRB- denotes (
T3807 309-319 NN denotes conditions
T3806 303-308 NN denotes serum
T3805 296-302 JJ denotes normal
T3804 290-295 IN denotes under
T3803 278-289 NN denotes necroptosis
T3802 261-277 JJ denotes zVAD.fmk-induced
T3801 251-260 VB denotes inhibited
T3800 242-250 RB denotes strongly
T3799 232-241 NN denotes signaling
T3798 227-231 NN denotes bFGF
T3797 224-226 IN denotes of
T3796 213-223 NN denotes inhibition
T3795 208-212 IN denotes that
T3794 197-207 VB denotes determined
T3793 193-196 CC denotes and
T3792 191-192 -COMMA- denotes ,
T3791 190-191 -RRB- denotes )
T3790 182-190 NN denotes PD166866
T3789 178-181 CC denotes and
T3788 169-177 NN denotes PD173074
T3787 168-169 -LRB- denotes (
T3786 157-167 NN denotes inhibitors
T3785 150-156 NN denotes kinase
T3784 141-149 NN denotes tyrosine
T3783 132-140 NN denotes receptor
T3782 127-131 NN denotes bFGF
T3781 123-126 CD denotes two
T3780 118-122 VB denotes used
T3779 115-117 PRP denotes We
T3778 112-113 -RRB- denotes )
T3777 109-112 NN denotes FBS
T3776 107-108 NN denotes %
T3775 105-107 CD denotes 10
T3774 104-105 -LRB- denotes (
T3773 93-103 NN denotes conditions
T3772 87-92 NN denotes serum
T3771 80-86 JJ denotes normal
T3770 74-79 IN denotes under
T3769 62-73 NN denotes necroptosis
T3768 45-61 JJ denotes zVAD.fmk-induced
T3767 42-44 TO denotes to
T3766 30-41 VB denotes contributes
T3765 25-29 NN denotes bFGF
T3764 17-24 IN denotes whether
T3763 8-16 VB denotes examined
T3762 3-7 RB denotes next
T3761 0-2 PRP denotes We
R2566 T3761 T3763 arg1Of We,examined
R2567 T3763 T3762 arg1Of examined,next
R2568 T3765 T3766 arg1Of bFGF,contributes
R2569 T3766 T3763 arg2Of contributes,examined
R2570 T3766 T3764 arg1Of contributes,whether
R2571 T3766 T3767 arg1Of contributes,to
R2572 T3766 T3770 arg1Of contributes,under
R2573 T3769 T3767 arg2Of necroptosis,to
R2574 T3769 T3768 arg1Of necroptosis,zVAD.fmk-induced
R2575 T3773 T3770 arg2Of conditions,under
R2576 T3773 T3771 arg1Of conditions,normal
R2577 T3773 T3772 arg1Of conditions,serum
R2578 T3773 T3774 arg1Of conditions,(
R2579 T3775 T3776 arg1Of 10,%
R2580 T3777 T3774 arg2Of FBS,(
R2581 T3777 T3775 arg1Of FBS,10
R2582 T3778 T3774 arg3Of ),(
R2583 T3779 T3780 arg1Of We,used
R2584 T3779 T3794 arg1Of We,determined
R2585 T3780 T3793 arg1Of used,and
R2586 T3786 T3780 arg2Of inhibitors,used
R2587 T3786 T3781 arg1Of inhibitors,two
R2588 T3786 T3782 arg1Of inhibitors,bFGF
R2589 T3786 T3783 arg1Of inhibitors,receptor
R2590 T3786 T3784 arg1Of inhibitors,tyrosine
R2591 T3786 T3785 arg1Of inhibitors,kinase
R2592 T3786 T3787 arg1Of inhibitors,(
R2593 T3788 T3789 arg1Of PD173074,and
R2594 T3789 T3787 arg2Of and,(
R2595 T3790 T3789 arg2Of PD166866,and
R2596 T3791 T3787 arg3Of ),(
R2597 T3793 T3792 arg1Of and,","
R2598 T3794 T3793 arg2Of determined,and
R2599 T3796 T3797 arg1Of inhibition,of
R2600 T3796 T3801 arg1Of inhibition,inhibited
R2601 T3799 T3797 arg2Of signaling,of
R2602 T3799 T3798 arg1Of signaling,bFGF
R2603 T3801 T3794 arg2Of inhibited,determined
R2604 T3801 T3795 arg1Of inhibited,that
R2605 T3801 T3800 arg1Of inhibited,strongly
R2606 T3801 T3804 arg1Of inhibited,under
R2607 T3803 T3801 arg2Of necroptosis,inhibited
R2608 T3803 T3802 arg1Of necroptosis,zVAD.fmk-induced
R2609 T3807 T3804 arg2Of conditions,under
R2610 T3807 T3805 arg1Of conditions,normal
R2611 T3807 T3806 arg1Of conditions,serum
R2612 T3807 T3808 arg1Of conditions,(
R2613 T3810 T3808 arg2Of 1D,(
R2614 T3810 T3809 arg1Of 1D,Fig.
R2615 T3811 T3808 arg3Of ),(
R2616 T3813 T3812 arg2Of contrast,In
R2617 T3818 T3815 arg1Of inhibitor,neither
R2618 T3818 T3816 arg1Of inhibitor,bFGF
R2619 T3818 T3817 arg1Of inhibitor,receptor
R2620 T3818 T3819 arg1Of inhibitor,was
R2621 T3818 T3820 arg1Of inhibitor,able
R2622 T3818 T3822 arg1Of inhibitor,attenuate
R2623 T3819 T3812 arg1Of was,In
R2624 T3819 T3814 arg1Of was,","
R2625 T3819 T3829 arg1Of was,","
R2626 T3819 T3830 arg1Of was,consistent
R2627 T3819 T3831 arg1Of was,with
R2628 T3820 T3819 arg2Of able,was
R2629 T3822 T3820 arg2Of attenuate,able
R2630 T3822 T3821 arg1Of attenuate,to
R2631 T3824 T3822 arg2Of necroptosis,attenuate
R2632 T3824 T3823 arg1Of necroptosis,TNFα-induced
R2633 T3824 T3825 arg1Of necroptosis,(
R2634 T3827 T3825 arg2Of 1D,(
R2635 T3827 T3826 arg1Of 1D,Fig.
R2636 T3828 T3825 arg3Of ),(
R2637 T3833 T3831 arg2Of factors,with
R2638 T3833 T3832 arg1Of factors,growth
R2639 T3833 T3834 arg1Of factors,being
R2640 T3833 T3835 arg1Of factors,dispensable
R2641 T3834 T3831 arg3Of being,with
R2642 T3835 T3834 arg2Of dispensable,being
R2643 T3835 T3836 arg1Of dispensable,for
R2644 T3838 T3836 arg2Of pathway,for
R2645 T3838 T3837 arg1Of pathway,this
R2646 T3838 T3839 arg1Of pathway,(
R2647 T3841 T3839 arg2Of 1A,(
R2648 T3841 T3840 arg1Of 1A,Fig.
R2649 T3842 T3839 arg3Of ),(
R2650 T3846 T3845 arg1Of data,these
R2651 T3846 T3847 arg1Of data,suggest
R2652 T3847 T3843 arg1Of suggest,Overall
R2653 T3847 T3844 arg1Of suggest,","
R2654 T3850 T3849 arg1Of induction,the
R2655 T3850 T3851 arg1Of induction,of
R2656 T3850 T3853 arg1Of induction,by
R2657 T3850 T3855 arg1Of induction,is
R2658 T3850 T3856 arg2Of induction,promoted
R2659 T3852 T3851 arg2Of necroptosis,of
R2660 T3854 T3853 arg2Of zVAD.fmk,by
R2661 T3856 T3847 arg2Of promoted,suggest
R2662 T3856 T3848 arg1Of promoted,that
R2663 T3856 T3855 arg2Of promoted,is
R2664 T3856 T3859 arg1Of promoted,under
R2665 T3858 T3856 arg1Of bFGF,promoted
R2666 T3858 T3857 arg2Of bFGF,by
R2667 T3861 T3862 arg1Of serum,and
R2668 T3863 T3862 arg2Of serum,and
R2669 T3865 T3859 arg2Of conditions,under
R2670 T3865 T3860 arg1Of conditions,both
R2671 T3865 T3861 arg1Of conditions,serum
R2672 T3865 T3863 arg1Of conditions,serum
R2673 T3865 T3864 arg1Of conditions,free
R2674 T3867 T3866 arg1Of induction,The
R2675 T3867 T3868 arg1Of induction,of
R2676 T3867 T3873 arg1Of induction,is
R2677 T3869 T3868 arg2Of necroptosis,of
R2678 T3873 T3870 arg1Of is,","
R2679 T3873 T3871 arg1Of is,however
R2680 T3873 T3872 arg1Of is,","
R2681 T3873 T3874 arg1Of is,not
R2682 T3873 T3882 arg1Of is,since
R2683 T3877 T3873 arg2Of consequence,is
R2684 T3877 T3875 arg1Of consequence,a
R2685 T3877 T3876 arg1Of consequence,simple
R2686 T3877 T3878 arg1Of consequence,of
R2687 T3881 T3878 arg2Of signaling,of
R2688 T3881 T3879 arg1Of signaling,growth
R2689 T3881 T3880 arg1Of signaling,factor
R2690 T3886 T3883 arg1Of factors,not
R2691 T3886 T3884 arg1Of factors,all
R2692 T3886 T3885 arg1Of factors,growth
R2693 T3886 T3887 arg1Of factors,allowed
R2694 T3887 T3882 arg2Of allowed,since
R2695 T3888 T3887 arg2Of death,allowed
R2696 T3888 T3890 arg1Of death,occur
R2697 T3890 T3887 arg3Of occur,allowed
R2698 T3890 T3889 arg1Of occur,to
R2699 T3895 T3893 arg1Of events,specific
R2700 T3895 T3894 arg1Of events,signaling
R2701 T3895 T3896 arg2Of events,mediated
R2702 T3895 T3901 arg1Of events,appear
R2703 T3895 T3903 arg1Of events,contribute
R2704 T3900 T3896 arg1Of factors,mediated
R2705 T3900 T3897 arg2Of factors,by
R2706 T3900 T3898 arg1Of factors,particular
R2707 T3900 T3899 arg1Of factors,growth
R2708 T3901 T3891 arg1Of appear,Instead
R2709 T3901 T3892 arg1Of appear,","
R2710 T3903 T3901 arg2Of contribute,appear
R2711 T3903 T3902 arg1Of contribute,to
R2712 T3903 T3904 arg1Of contribute,to
R2713 T3906 T3904 arg2Of death,to
R2714 T3906 T3905 arg1Of death,necroptotic

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T3065 352-365 Protein denotes bFGF receptor
T3064 227-231 Protein denotes bFGF
T3063 127-156 Protein denotes bFGF receptor tyrosine kinase
T3062 25-29 Protein denotes bFGF
T3067 600-604 Protein denotes bFGF
T3066 398-402 Protein denotes TNFα

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T3973 600-604 http://www.uniprot.org/uniprot/Q788Q8 denotes bFGF
T3972 352-356 http://www.uniprot.org/uniprot/Q788Q8 denotes bFGF
T3971 227-231 http://www.uniprot.org/uniprot/Q788Q8 denotes bFGF
T3970 127-131 http://www.uniprot.org/uniprot/Q788Q8 denotes bFGF
T3969 25-29 http://www.uniprot.org/uniprot/Q788Q8 denotes bFGF
T3958 398-402 http://www.uniprot.org/uniprot/P01375 denotes TNFα

UBERON-AE

Id Subject Object Predicate Lexical cue
T2971 626-631 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum
T2970 616-621 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum
T2969 303-308 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum
T2968 87-92 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum

GO-BP

Id Subject Object Predicate Lexical cue
T3153 150-167 http://purl.obolibrary.org/obo/GO_0033673 denotes kinase inhibitors
T3152 132-156 http://purl.obolibrary.org/obo/GO_0038083 denotes receptor tyrosine kinase
T3149 814-823 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T3148 733-742 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T3147 232-241 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T3132 905-910 http://purl.obolibrary.org/obo/GO_0016265 denotes death
T3131 780-785 http://purl.obolibrary.org/obo/GO_0016265 denotes death
T3116 666-677 http://purl.obolibrary.org/obo/GO_0097528 denotes necroptosis
T3115 561-572 http://purl.obolibrary.org/obo/GO_0097528 denotes necroptosis
T3114 411-422 http://purl.obolibrary.org/obo/GO_0097528 denotes necroptosis
T3113 278-289 http://purl.obolibrary.org/obo/GO_0097528 denotes necroptosis
T3112 62-73 http://purl.obolibrary.org/obo/GO_0097528 denotes necroptosis
T3098 653-677 http://purl.obolibrary.org/obo/GO_0070266 denotes induction of necroptosis
T3097 548-572 http://purl.obolibrary.org/obo/GO_0070266 denotes induction of necroptosis
T3095 561-572 http://purl.obolibrary.org/obo/GO_0070266 denotes necroptosis
T3094 411-422 http://purl.obolibrary.org/obo/GO_0070266 denotes necroptosis
T3093 278-289 http://purl.obolibrary.org/obo/GO_0070266 denotes necroptosis
T3092 62-73 http://purl.obolibrary.org/obo/GO_0070266 denotes necroptosis
T3078 854-860 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T3077 757-763 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T3076 719-725 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T3075 450-456 http://purl.obolibrary.org/obo/GO_0040007 denotes growth

GO-MF

Id Subject Object Predicate Lexical cue
T3161 132-156 http://purl.obolibrary.org/obo/GO_0030971 denotes receptor tyrosine kinase

sentences

Id Subject Object Predicate Lexical cue
T2993 796-911 Sentence denotes Instead, specific signaling events mediated by particular growth factors appear to contribute to necroptotic death.
T2992 649-795 Sentence denotes The induction of necroptosis, however, is not a simple consequence of growth factor signaling since not all growth factors allowed death to occur.
T2991 511-648 Sentence denotes Overall, these data suggest that the induction of necroptosis by zVAD.fmk is promoted by bFGF under both serum and serum free conditions.
T2990 331-510 Sentence denotes In contrast, neither bFGF receptor inhibitor was able to attenuate TNFα-induced necroptosis (Fig. 1D), consistent with growth factors being dispensable for this pathway (Fig. 1A).
T2989 115-330 Sentence denotes We used two bFGF receptor tyrosine kinase inhibitors (PD173074 and PD166866), and determined that inhibition of bFGF signaling strongly inhibited zVAD.fmk-induced necroptosis under normal serum conditions (Fig. 1D).
T2988 0-114 Sentence denotes We next examined whether bFGF contributes to zVAD.fmk-induced necroptosis under normal serum conditions (10% FBS).
T58 0-114 Sentence denotes We next examined whether bFGF contributes to zVAD.fmk-induced necroptosis under normal serum conditions (10% FBS).
T59 115-330 Sentence denotes We used two bFGF receptor tyrosine kinase inhibitors (PD173074 and PD166866), and determined that inhibition of bFGF signaling strongly inhibited zVAD.fmk-induced necroptosis under normal serum conditions (Fig. 1D).
T60 331-510 Sentence denotes In contrast, neither bFGF receptor inhibitor was able to attenuate TNFα-induced necroptosis (Fig. 1D), consistent with growth factors being dispensable for this pathway (Fig. 1A).
T61 511-648 Sentence denotes Overall, these data suggest that the induction of necroptosis by zVAD.fmk is promoted by bFGF under both serum and serum free conditions.
T62 649-795 Sentence denotes The induction of necroptosis, however, is not a simple consequence of growth factor signaling since not all growth factors allowed death to occur.
T63 796-911 Sentence denotes Instead, specific signaling events mediated by particular growth factors appear to contribute to necroptotic death.

simple1

Id Subject Object Predicate Lexical cue
T3199 600-604 Protein denotes bFGF
T3198 398-402 Protein denotes TNFα
T3197 352-365 Protein denotes bFGF receptor
T3196 227-231 Protein denotes bFGF
T3195 127-156 Protein denotes bFGF receptor tyrosine kinase
T3194 25-29 Protein denotes bFGF

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T3945 600-604 Protein denotes bFGF
T3944 398-402 Protein denotes TNFα
T3943 352-365 Protein denotes bFGF receptor
T3942 227-231 Protein denotes bFGF
T3941 127-156 Protein denotes bFGF receptor tyrosine kinase
T3940 25-29 Protein denotes bFGF
T3952 366-375 Negative_regulation denotes inhibitor
T3951 157-167 Negative_regulation denotes inhibitors
R2723 T3941 T3951 themeOf bFGF receptor tyrosine kinase,inhibitors
R2724 T3943 T3952 themeOf bFGF receptor,inhibitor

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T4076 600-604 Protein denotes bFGF
T4075 398-402 Protein denotes TNFα
T4074 352-365 Protein denotes bFGF receptor
T4073 227-231 Protein denotes bFGF
T4072 127-156 Protein denotes bFGF receptor tyrosine kinase
T4071 25-29 Protein denotes bFGF
T4082 403-410 Positive_regulation denotes induced
T4081 366-375 Negative_regulation denotes inhibitor
T4080 157-167 Negative_regulation denotes inhibitors
R2748 T4072 T4080 themeOf bFGF receptor tyrosine kinase,inhibitors
R2749 T4074 T4081 themeOf bFGF receptor,inhibitor
R2750 T4075 T4082 themeOf TNFα,induced

DLUT931

Id Subject Object Predicate Lexical cue
T4013 366-375 Negative_regulation denotes inhibitor
T4012 213-223 Negative_regulation denotes inhibition
T4011 157-167 Negative_regulation denotes inhibitors
T4002 600-604 Protein denotes bFGF
T4001 398-402 Protein denotes TNFα
T4000 352-365 Protein denotes bFGF receptor
T3999 227-231 Protein denotes bFGF
T3998 127-156 Protein denotes bFGF receptor tyrosine kinase
T3997 25-29 Protein denotes bFGF
R2735 T3998 T4011 themeOf bFGF receptor tyrosine kinase,inhibitors
R2736 T3999 T4012 themeOf bFGF,inhibition
R2737 T4000 T4013 themeOf bFGF receptor,inhibitor

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T4930 45-61 Entity denotes zVAD.fmk-induced
T4927 105-112 Protein denotes 10% FBS
T4926 719-732 Protein denotes growth factor
T4922 227-231 Protein denotes bFGF
T4919 398-410 Protein denotes TNFα-induced
T4989 115-241 Negative_regulation denotes We used two bFGF receptor tyrosine kinase inhibitors (PD173074 and PD166866), and determined that inhibition of bFGF signaling
T4988 716-742 Positive_regulation denotes of growth factor signaling
T4987 224-241 Positive_regulation denotes of bFGF signaling
T4979 357-365 Protein denotes receptor
T4971 424-427 Protein denotes Fig
T4970 261-269 Entity denotes zVAD.fmk
T4969 573-584 Entity denotes by zVAD.fmk
T4959 352-356 Protein denotes bFGF
T4956 321-324 Protein denotes Fig
T4953 123-192 Protein denotes two bFGF receptor tyrosine kinase inhibitors (PD173074 and PD166866),
T4948 25-29 Protein denotes bFGF
T4947 123-192 Entity denotes two bFGF receptor tyrosine kinase inhibitors (PD173074 and PD166866),
T4944 357-375 Entity denotes receptor inhibitor
T4940 597-604 Protein denotes by bFGF
T4939 127-131 Protein denotes bFGF
R3461 T4922 T4987 causeOf bFGF,of bFGF signaling
R3463 T4926 T4988 causeOf growth factor,of growth factor signaling
R3495 T4987 T4989 themeOf of bFGF signaling,"We used two bFGF receptor tyrosine kinase inhibitors (PD173074 and PD166866), and determined that inhibition of bFGF signaling"

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T4857 910-911 . denotes .
T4856 905-910 NN denotes death
T4855 893-904 JJ denotes necroptotic
T4854 890-892 TO denotes to
T4853 879-889 VB denotes contribute
T4852 876-878 TO denotes to
T4851 869-875 VBP denotes appear
T4850 861-868 NNS denotes factors
T4849 854-860 NN denotes growth
T4848 843-853 JJ denotes particular
T4847 840-842 IN denotes by
T4846 831-839 VBN denotes mediated
T4845 824-830 NNS denotes events
T4844 814-823 VBG denotes signaling
T4843 805-813 JJ denotes specific
T4842 803-804 , denotes ,
T4841 796-803 RB denotes Instead
T4840 794-795 . denotes .
T4839 789-794 VB denotes occur
T4838 786-788 TO denotes to
T4837 780-785 NN denotes death
T4836 772-779 VBD denotes allowed
T4835 764-771 NNS denotes factors
T4834 757-763 NN denotes growth
T4833 753-756 DT denotes all
T4832 749-752 RB denotes not
T4831 743-748 IN denotes since
T4830 733-742 VBG denotes signaling
T4829 726-732 NN denotes factor
T4828 719-725 NN denotes growth
T4827 716-718 IN denotes of
T4826 704-715 NN denotes consequence
T4825 697-703 JJ denotes simple
T4824 695-696 DT denotes a
T4823 691-694 RB denotes not
T4822 688-690 VBZ denotes is
T4821 686-687 , denotes ,
T4820 679-686 RB denotes however
T4819 677-678 , denotes ,
T4818 666-677 NN denotes necroptosis
T4817 663-665 IN denotes of
T4816 653-662 NN denotes induction
T4815 649-652 DT denotes The
T4814 647-648 . denotes .
T4813 637-647 NNS denotes conditions
T4812 632-636 JJ denotes free
T4811 626-631 NN denotes serum
T4810 622-625 CC denotes and
T4809 616-621 NN denotes serum
T4808 611-615 DT denotes both
T4807 605-610 IN denotes under
T4806 600-604 NNP denotes bFGF
T4805 597-599 IN denotes by
T4804 588-596 VBN denotes promoted
T4803 585-587 VBZ denotes is
T4802 576-584 NNP denotes zVAD.fmk
T4801 573-575 IN denotes by
T4800 561-572 NN denotes necroptosis
T4799 558-560 IN denotes of
T4798 548-557 NN denotes induction
T4797 544-547 DT denotes the
T4796 539-543 IN denotes that
T4795 531-538 VBP denotes suggest
T4794 526-530 NNS denotes data
T4793 520-525 DT denotes these
T4792 518-519 , denotes ,
T4791 511-518 RB denotes Overall
T4790 509-510 . denotes .
T4789 508-509 -RRB- denotes )
T4788 506-508 NNP denotes 1A
T4787 501-505 NNP denotes Fig.
T4786 500-501 -LRB- denotes (
T4785 492-499 NN denotes pathway
T4784 487-491 DT denotes this
T4783 483-486 IN denotes for
T4782 471-482 JJ denotes dispensable
T4781 465-470 VBG denotes being
T4780 457-464 NNS denotes factors
T4779 450-456 NN denotes growth
T4778 445-449 IN denotes with
T4777 434-444 JJ denotes consistent
T4776 432-433 , denotes ,
T4775 431-432 -RRB- denotes )
T4774 429-431 NNP denotes 1D
T4773 424-428 NNP denotes Fig.
T4772 423-424 -LRB- denotes (
T4771 411-422 NN denotes necroptosis
T4770 398-410 JJ denotes TNFα-induced
T4769 388-397 VB denotes attenuate
T4768 385-387 TO denotes to
T4767 380-384 JJ denotes able
T4766 376-379 VBD denotes was
T4765 366-375 NN denotes inhibitor
T4764 357-365 NN denotes receptor
T4763 352-356 NN denotes bFGF
T4762 344-351 DT denotes neither
T4761 342-343 , denotes ,
T4760 334-342 NN denotes contrast
T4759 331-333 IN denotes In
T4758 329-330 . denotes .
T4757 328-329 -RRB- denotes )
T4756 326-328 NNP denotes 1D
T4755 321-325 NNP denotes Fig.
T4754 320-321 -LRB- denotes (
T4753 309-319 NNS denotes conditions
T4752 303-308 NN denotes serum
T4751 296-302 JJ denotes normal
T4750 290-295 IN denotes under
T4749 278-289 NN denotes necroptosis
T4748 261-277 JJ denotes zVAD.fmk-induced
T4747 251-260 VBN denotes inhibited
T4746 242-250 RB denotes strongly
T4745 232-241 VBG denotes signaling
T4744 227-231 NNP denotes bFGF
T4743 224-226 IN denotes of
T4742 213-223 NN denotes inhibition
T4741 208-212 IN denotes that
T4740 197-207 VBD denotes determined
T4739 193-196 CC denotes and
T4738 191-192 , denotes ,
T4737 190-191 -RRB- denotes )
T4736 182-190 NNP denotes PD166866
T4735 178-181 CC denotes and
T4734 169-177 CD denotes PD173074
T4733 168-169 -LRB- denotes (
T4732 157-167 NNS denotes inhibitors
T4731 150-156 NN denotes kinase
T4730 141-149 NN denotes tyrosine
T4729 132-140 NN denotes receptor
T4728 127-131 NN denotes bFGF
T4727 123-126 CD denotes two
T4726 118-122 VBD denotes used
T4725 115-117 PRP denotes We
T4724 113-114 . denotes .
T4723 112-113 -RRB- denotes )
T4722 109-112 NNP denotes FBS
T4721 107-108 NN denotes %
T4720 105-107 CD denotes 10
T4719 104-105 -LRB- denotes (
T4718 93-103 NNS denotes conditions
T4717 87-92 NN denotes serum
T4716 80-86 JJ denotes normal
T4715 74-79 IN denotes under
T4714 62-73 NN denotes necroptosis
T4713 45-61 JJ denotes zVAD.fmk-induced
T4712 42-44 TO denotes to
T4711 30-41 VBZ denotes contributes
T4710 25-29 NNP denotes bFGF
T4709 17-24 IN denotes whether
T4708 8-16 VBD denotes examined
T4707 3-7 JJ denotes next
T4706 0-2 PRP denotes We
R3309 T4706 T4708 nsubj We,examined
R3310 T4707 T4708 advmod next,examined
R3312 T4708 T4708 ROOT examined,examined
R3313 T4709 T4711 mark whether,contributes
R3315 T4710 T4711 nsubj bFGF,contributes
R3316 T4711 T4708 ccomp contributes,examined
R3318 T4712 T4711 prep to,contributes
R3319 T4713 T4714 amod zVAD.fmk-induced,necroptosis
R3321 T4714 T4712 pobj necroptosis,to
R3322 T4715 T4711 prep under,contributes
R3324 T4716 T4718 amod normal,conditions
R3325 T4717 T4718 compound serum,conditions
R3326 T4718 T4715 pobj conditions,under
R3330 T4719 T4722 punct (,FBS
R3331 T4720 T4721 nummod 10,%
R3333 T4721 T4722 compound %,FBS
R3334 T4722 T4718 appos FBS,conditions
R3335 T4723 T4711 punct ),contributes
R3337 T4724 T4708 punct .,examined
R3338 T4725 T4726 nsubj We,used
R3339 T4726 T4726 ROOT used,used
R3341 T4727 T4732 nummod two,inhibitors
R3342 T4728 T4732 nmod bFGF,inhibitors
R3344 T4729 T4732 nmod receptor,inhibitors
R3345 T4730 T4732 nmod tyrosine,inhibitors
R3346 T4731 T4732 compound kinase,inhibitors
R3348 T4732 T4726 dobj inhibitors,used
R3349 T4733 T4732 punct (,inhibitors
R3350 T4734 T4732 appos PD173074,inhibitors
R3351 T4735 T4734 cc and,PD173074
R3352 T4736 T4734 conj PD166866,PD173074
R3353 T4737 T4736 punct ),PD166866
R3355 T4738 T4732 punct ",",inhibitors
R3356 T4739 T4726 cc and,used
R3357 T4740 T4726 conj determined,used
R3359 T4741 T4747 mark that,inhibited
R3360 T4742 T4747 nsubj inhibition,inhibited
R3361 T4743 T4742 prep of,inhibition
R3363 T4744 T4743 pobj bFGF,of
R3364 T4745 T4742 acl signaling,inhibition
R3365 T4746 T4747 advmod strongly,inhibited
R3366 T4747 T4740 ccomp inhibited,determined
R3368 T4748 T4749 amod zVAD.fmk-induced,necroptosis
R3369 T4749 T4747 dobj necroptosis,inhibited
R3370 T4750 T4747 prep under,inhibited
R3371 T4780 T4781 nsubj factors,being
R3372 T4751 T4753 amod normal,conditions
R3373 T4781 T4778 pcomp being,with
R3374 T4752 T4753 compound serum,conditions
R3375 T4753 T4750 pobj conditions,under
R3376 T4754 T4756 punct (,1D
R3377 T4782 T4781 acomp dispensable,being
R3378 T4755 T4756 compound Fig.,1D
R3379 T4756 T4753 appos 1D,conditions
R3380 T4757 T4747 punct ),inhibited
R3381 T4783 T4782 prep for,dispensable
R3382 T4758 T4726 punct .,used
R3383 T4759 T4766 prep In,was
R3384 T4760 T4759 pobj contrast,In
R3385 T4784 T4785 det this,pathway
R3386 T4785 T4783 pobj pathway,for
R3387 T4761 T4766 punct ",",was
R3388 T4786 T4785 punct (,pathway
R3389 T4762 T4765 det neither,inhibitor
R3390 T4763 T4765 compound bFGF,inhibitor
R3391 T4787 T4788 compound Fig.,1A
R3392 T4764 T4765 compound receptor,inhibitor
R3393 T4765 T4766 nsubj inhibitor,was
R3394 T4766 T4766 ROOT was,was
R3395 T4788 T4785 appos 1A,pathway
R3396 T4767 T4766 acomp able,was
R3397 T4768 T4769 aux to,attenuate
R3398 T4789 T4785 punct ),pathway
R3399 T4769 T4767 xcomp attenuate,able
R3400 T4770 T4771 amod TNFα-induced,necroptosis
R3401 T4771 T4769 dobj necroptosis,attenuate
R3402 T4772 T4771 punct (,necroptosis
R3403 T4773 T4774 compound Fig.,1D
R3404 T4774 T4771 appos 1D,necroptosis
R3405 T4775 T4771 punct ),necroptosis
R3406 T4790 T4766 punct .,was
R3407 T4776 T4771 punct ",",necroptosis
R3408 T4777 T4769 prep consistent,attenuate
R3409 T4778 T4777 prep with,consistent
R3410 T4791 T4795 advmod Overall,suggest
R3411 T4779 T4780 compound growth,factors
R3412 T4792 T4795 punct ",",suggest
R3413 T4793 T4794 det these,data
R3414 T4794 T4795 nsubj data,suggest
R3415 T4795 T4795 ROOT suggest,suggest
R3416 T4796 T4804 mark that,promoted
R3417 T4797 T4798 det the,induction
R3418 T4798 T4804 nsubjpass induction,promoted
R3419 T4799 T4798 prep of,induction
R3421 T4800 T4799 pobj necroptosis,of
R3422 T4801 T4798 prep by,induction
R3425 T4802 T4801 pobj zVAD.fmk,by
R3427 T4803 T4804 auxpass is,promoted
R3428 T4804 T4795 ccomp promoted,suggest
R3429 T4805 T4804 agent by,promoted
R3430 T4806 T4805 pobj bFGF,by
R3432 T4807 T4804 prep under,promoted
R3433 T4808 T4809 det both,serum
R3435 T4809 T4807 pobj serum,under
R3436 T4810 T4809 cc and,serum
R3438 T4811 T4813 nmod serum,conditions
R3439 T4812 T4813 amod free,conditions
R3441 T4813 T4809 conj conditions,serum
R3442 T4814 T4795 punct .,suggest
R3443 T4815 T4816 det The,induction
R3444 T4816 T4822 nsubj induction,is
R3445 T4817 T4816 prep of,induction
R3446 T4818 T4817 pobj necroptosis,of
R3448 T4819 T4822 punct ",",is
R3449 T4820 T4822 advmod however,is
R3450 T4821 T4822 punct ",",is
R3451 T4822 T4822 ROOT is,is
R3452 T4823 T4822 neg not,is
R3453 T4824 T4826 det a,consequence
R3454 T4825 T4826 amod simple,consequence
R3455 T4826 T4822 attr consequence,is
R3456 T4827 T4826 prep of,consequence
R3457 T4828 T4829 compound growth,factor
R3459 T4829 T4827 pobj factor,of
R3460 T4830 T4829 acl signaling,factor
R3462 T4831 T4836 mark since,allowed
R3464 T4832 T4835 neg not,factors
R3465 T4833 T4835 det all,factors
R3467 T4834 T4835 compound growth,factors
R3468 T4835 T4836 nsubj factors,allowed
R3469 T4836 T4826 advcl allowed,consequence
R3470 T4837 T4839 nsubj death,occur
R3471 T4838 T4839 aux to,occur
R3472 T4839 T4836 ccomp occur,allowed
R3473 T4840 T4822 punct .,is
R3474 T4841 T4851 advmod Instead,appear
R3475 T4842 T4851 punct ",",appear
R3477 T4843 T4845 amod specific,events
R3478 T4844 T4845 amod signaling,events
R3479 T4845 T4851 nsubj events,appear
R3480 T4846 T4845 acl mediated,events
R3481 T4847 T4846 agent by,mediated
R3482 T4848 T4850 amod particular,factors
R3483 T4849 T4850 compound growth,factors
R3484 T4850 T4847 pobj factors,by
R3485 T4851 T4851 ROOT appear,appear
R3487 T4852 T4853 aux to,contribute
R3489 T4853 T4851 xcomp contribute,appear
R3490 T4854 T4853 prep to,contribute
R3491 T4855 T4856 amod necroptotic,death
R3493 T4856 T4854 pobj death,to
R3494 T4857 T4851 punct .,appear

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T4139 600-604 Protein denotes bFGF
T4138 576-584 Protein denotes zVAD.fmk
T4137 366-375 Negative_regulation denotes inhibitor
T4136 398-402 Protein denotes TNFα
T4135 352-365 Protein denotes bFGF receptor
T4134 266-269 Protein denotes fmk
T4133 261-265 Protein denotes zVAD
T4132 227-231 Protein denotes bFGF
T4131 127-156 Protein denotes bFGF receptor tyrosine kinase
T4130 25-29 Protein denotes bFGF
R2759 T4135 T4137 themeOf bFGF receptor,inhibitor

test3

Id Subject Object Predicate Lexical cue
T2956 600-604 Protein denotes bFGF
T2955 588-596 Positive_regulation denotes promoted
T2954 548-557 Positive_regulation denotes induction
T2953 403-410 Positive_regulation denotes induced
T2952 398-402 Protein denotes TNFα
T2951 352-365 Protein denotes bFGF receptor
T2950 227-231 Protein denotes bFGF
T2949 127-156 Protein denotes bFGF receptor tyrosine kinase
T2948 25-29 Protein denotes bFGF
T2922 600-604 Protein denotes bFGF
T2921 398-402 Protein denotes TNFα
T2920 352-365 Protein denotes bFGF receptor
T2919 227-231 Protein denotes bFGF
T2918 127-156 Protein denotes bFGF receptor tyrosine kinase
T2917 25-29 Protein denotes bFGF
R1991 T2954 T2955 themeOf induction,promoted
R1992 T2956 T2955 causeOf bFGF,promoted